Fairvalue-Calculator Fairvalue-Calculator
EN DE

PanGen Biotech Inc (222110) Fair Value & Analysis

Healthcare · KR · Market cap 65.2B KRW

Price4,595 KRW
Fair Value1,395 KRW
Upside-69.7%
Quality95/100
Evidence: High Range 1,235 KRW – 1,534 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

PanGen Biotech Inc (222110) currently trades at 4,595 KRW, while our model-based Fair Value estimate is 1,395 KRW — implying the stock looks roughly 69.7% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

PanGen Biotech Inc. operates as a biologics company in South Korea. It develops biosimilar products, such as EPO, recombinant factor VIII, G-CSF, etc. The company also provides CHO cell lines for proteins and monoclonal antibodies; and one-stop services ranging from producer cell line development to GMP production. In addition, it offers reagents, quantitation kits, and cell based assay systems, as well as technology transfer service. PanGen Biotech Inc. was founded in 1999 and is based in Suwon-si, South Korea.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -38% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -27% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) -28% Alnylam Pharmaceuticals, Inc (ALNY) -63%

Frequently asked questions

Is PanGen Biotech Inc (222110) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 1,395 KRW versus a price of 4,595 KRW — about −70% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 222110?
Our 21-model fair value for PanGen Biotech Inc is 1,395 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 4,595 KRW.
What is the quality score of 222110?
PanGen Biotech Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.